bpc 157 fda approved BPC-157 Legal Status: Regulations and Compounding FDA advisory committee votes to

Megaloblastic anemia caused by vitamin B12 deficiency

Injectable BPC-157 (subcutaneous or intramuscular) bypasses gastric proteolysis entirely and is the route used in virtually all positive rodent studies on non-GI outcomes

Inositol is a vitamin B complex nutrient that can help control mood and appetite by affecting serotonin levels

Both are schedules described in research, not prescriptions

However, a unique feature that may help mitigate the potential placebo effects is that the treatment benefits typically wear off 12 weeks prior to the next scheduled injection, and the benefits are reinstated following each injection

At Moonshot Medical, we coordinate peptide therapy with our physical rehabilitation program for a comprehensive recovery approach